Back to Search
Start Over
Novartis Farmaceutica, S.A. secures contract for Pharmaceutical products - Exclusive Medicines: Omalizumab (xolair), Ranibizumab (Lunteis), Everololimus (Votubia), Basiliximab (Simulc) 3rd Proroga PNSP 21|2019
- Source :
- Pivotal Sources. February 27, 2023
- Publication Year :
- 2023
-
Abstract
- Spain based Novartis Farmaceutica, S.A. has secured contract from Servicio Madrileno de Salud, Hospital Universitario La Paz for Pharmaceutical products - Exclusive Medicines: Omalizumab (xolair), Ranibizumab (Lunteis), Everololimus (Votubia), Basiliximab [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Pivotal Sources
- Publication Type :
- News
- Accession number :
- edsgcl.738857675